The U.K. will experience one of the highest growth rates for colonoscopy procedures in Europe due to the NHS Bowel Cancer Screening Program. This program encourages individuals, aged 60-69 to undergo a colon screening every two years.
Vancouver, BC (PRWEB) May 13, 2014
According to a new report by iData Research (http://www.idataresearch.com), the leading global authority in medical device market research, the European Gastrointestinal (GI) Endoscope Devices Market will grow to over $600 million by 2020. This growth will be fueled by an increase in public awareness about the risks of colorectal cancer and the advantages of early treatment, leading more individuals to undergo screenings and driving the markets for GI endoscopes, instrumentation and accessories.
There were over 26 million procedures performed in the gastrointestinal endoscopic device market in 2013. The majority of these procedures were screenings related to colon cancer, or the removal of abnormalities from the GI tract. “The U.K. will experience one of the highest growth rates for colonoscopy procedures in Europe due to the NHS Bowel Cancer Screening Program,” says Dr. Kamran Zamanian, CEO of iData. “This program encourages individuals, aged 60-69 to undergo a colon screening every two years.”
New generations of endoscopes will continue to progressively improve on visualization and detection technologies. Additionally, innovative systems such as SpectraScience’s proprietary WavSTAT4™ Optical Biopsy System, capable of quickly determining whether tissue is normal or cancerous during an endoscopy, will continue to make endoscopy more effective and cost-conscious. Other leading competitors driving this market are Olympus, Boston Scientific, Pentax, Fujinon, Karl Storz and Cook Medical.
Countries with the fastest GI Endoscope market growth rates in Europe are Portugal, Switzerland, Austria and Scandinavia, which are driven primarily by growth in unit volumes. Germany is the largest market but, is expected to see slower growth rates due to their earlier adoption of new technologies.
For Further Information
The global series on the “Markets for Gastrointestinal Endoscopic Devices” covers 21 countries including the U.S., Canada, Japan, India, China and 15 Countries in Europe. The full reports provide a comprehensive analysis including procedure numbers, units sold, market value, forecasts, as well as a detailed competitive market shares and analysis of major players’ success strategies in each market and segment.
Markets covered include: GI endoscopes, capsule endoscopy, virtual colonoscopy, stenting and dilation devices, ERCP devices, biopsy forceps, polypectomy snares, FNA devices, specimen and foreign body removal devices, hemostasis devices, anti-reflux devices, and enteral feeding devices.
Receive a free synopsis of this report here
About iData Research
iData Research (http://www.idataresearch.com) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Diabetes Drugs, Diabetes Devices, Pharmaceuticals, Anesthesiology, Wound Management, Orthopedics, Cardiovascular, Ophthalmic, Endoscopy, Gynecology, Urology and more.